Brief: Vicore Pharma: Positive Top Line Data From ATTRACT Clinical Study In Patients With Covid-19

Vicore Pharma Holding AB

08/12/2020 07:06

Dec 8 (Reuters) - Vicore Pharma Holding AB  VICOR.ST :
    * VICORE PHARMA REPORTS POSITIVE TOP LINE DATA FROM THE
ATTRACT
CLINICAL STUDY IN PATIENTS WITH COVID-19
    * POSITIVE TOP LINE DATA FROM ATTRACT COVID-19 TRIAL WITH
C21
(VP01)
    * C21 WAS WELL TOLERATED IN THIS POPULATION OF SEVERELY SICK
PATIENTS.
    * VICORE PHARMA WILL CONTINUE TO ANALYZE DATA FROM STUDY AND
MORE
INFORMATION WILL BE PRESENTED IN DUE COURSE.
    * C21 REDUCED RISK OF NEEDING OXYGEN AT END OF TREATMENT BY
40 %

Source text for Eikon:  ID:nWkr1371St 
Further company coverage:  VICOR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))